Skip to main content

Natalie Sacks

Equibles does not estimate personal net worth.

About Natalie Sacks

Natalie Sacks is recorded as Board Member at Caribou Biosciences, Inc. (CRBU). The newest filing on record that lists Natalie Sacks as Board Member at Caribou Biosciences, Inc. (CRBU) is dated April 24, 2026. Zymeworks Inc. reported in an 8-K filed June 29, 2023 that Natalie Sacks resigned as director, effective June 30, 2023. Caribou Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caribou Biosciences, Inc. includes Rachel Haurwitz (CEO and Board Member), Sriram Ryali (CFO), Tim Kelly (CTO) and 7 others.

“In addition, on June 26, 2023, Dr. Natalie Sacks submitted her resignation from the Board, including the nominating and corporate governance committee and the research and development committee of the Board, effective June 30, 2023.”
Zymeworks Inc. Form 8-K, filed June 29, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Caribou Biosciences, Inc.

Recent activity